Astera Labs, Inc. ALAB
Set alert
245.48 USD +15.81 +6.88%
As of Nov 3, 9:52 AM ET
235.33 Day range 249.46
100.27 52-week range 483.02
- YTD
- +47.56%
- 1 year
- +28.15%
- Open
- 236.20
- Prev close
- 229.67
- Mkt cap
- 42.45B
- Vol
- 566.74K
- Avg vol
- 4.09M
- EPS
- 2.03
- P/E
- 120.55
- Div yield
- 0.00%
More statistics
- Low
- 235.33
- High
- 249.46
- Forward P/E
- 35.31
- Beta
- 3.86
- Short ratio
- 1.86
- Inst. own
- 75.54%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 3, 2026
- 50-d avg
- 308.12
- 200-d avg
- 255.24
- 1y target
- 382.68
MAX chart
Events in this range
- Aug 5, 2025Earnings: 0.44; estimate 0.3241; surprise 35.76%
- Nov 4, 2025Earnings: 0.49; estimate 0.3899; surprise 25.67%
- Feb 10, 2026Earnings: 0.58; estimate 0.516; surprise 12.4%
- May 5, 2026Earnings: 0.61; estimate 0.537; surprise 13.59%
- Aug 4, 2026Earnings: 0.8; estimate 0.691; surprise 15.77%
- Aug 5, 2026Rating: Evercore ISI Group · Outperform → Outperform
- Aug 5, 2026Rating: RBC Capital · Outperform → Outperform
- Aug 5, 2026Rating: Morgan Stanley · Overweight → Overweight
- Aug 5, 2026Rating: TD Cowen · Hold → Hold
- Aug 17, 2026Rating: Northland Capital Markets · Market Perform → Outperform
- Oct 19, 2026Rating: TD Cowen · Hold → Hold
- Nov 3, 2026Earnings: —; estimate 1.19; surprise —%
Signals (32)
| Name | Date | Ago |
|---|---|---|
| SMA: Bearish | Oct 12, 2026 | 3 weeks ago |
| SMA: Bearish | Oct 12, 2026 | 3 weeks ago |
| SMA: Bullish | Sep 21, 2026 | 1 month ago |
| MACD: Sell Signal | Jul 27, 2026 | 3 months ago |
| SMA: Bearish | Jul 13, 2026 | 3 months ago |
| RSI: Overbought | May 18, 2026 | 5 months ago |
| SMA: Bullish | Apr 13, 2026 | 6 months ago |
| MACD: Buy Signal | Apr 13, 2026 | 6 months ago |
| SMA: Bullish | Apr 6, 2026 | 7 months ago |
| SMA: Bearish | Feb 9, 2026 | 8 months ago |
| SMA: Bullish | Feb 2, 2026 | 9 months ago |
| SMA: Bearish | Jan 26, 2026 | 9 months ago |
| SMA: Bearish | Jan 26, 2026 | 9 months ago |
| SMA: Bullish | Dec 15, 2025 | 10 months ago |
| SMA: Bullish | Dec 15, 2025 | 10 months ago |
| SMA: Bearish | Dec 8, 2025 | 11 months ago |
| SMA: Bullish | Nov 24, 2025 | 11 months ago |
| SMA: Bearish | Nov 17, 2025 | 11 months ago |
| MACD: Sell Signal | Oct 20, 2025 | 1 year ago |
| SMA: Bearish | Oct 13, 2025 | 1 year ago |
Newest 20 of 32.
Financial health
Altman Z-Score
118.44 Safe zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
4 / 9 Average
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
B-2 / 5 overall
- DCF 1
- Return on Equity 5
- Return on Assets 5
- Debt / Equity 1
- P/E 1
- P/B 1
Valuation
P/E 126×
FY 2022 5y median -172× FY 2025
P/S 32.5×
FY 2022 5y median 62.8× FY 2025
P/B 20.3×
FY 2022 5y median 19.2× FY 2025
P/FCF 98.3×
FY 2022 5y median -52.6× FY 2025
EV/EBITDA 122×
FY 2022 5y median -181× FY 2025
EV/Sales 32.3×
FY 2022 5y median 62.5× FY 2025
FCF Yield 1.0%
FY 2022 5y median 0.2% FY 2025
Profitability
Gross Margin 75.7%
FY 2022 5y median 74.6% FY 2025
Operating Margin 20.3%
FY 2022 5y median -27.4% FY 2025
Net Margin 25.7%
FY 2022 5y median -21.9% FY 2025
ROE 16.1%
FY 2022 5y median 3.7% FY 2025
ROIC 12.4%
FY 2022 5y median -15.0% FY 2025
ROA 14.3%
FY 2022 5y median -10.6% FY 2025
Growth (YoY)
Revenue 115.1%
FY 2022 FY 2025
Operating Income 249.4%
FY 2022 FY 2025
EPS (diluted) 290.6%
FY 2022 FY 2025
Free Cash Flow 175.1%
FY 2022 FY 2025
Financial Health
Current Ratio 10.2×
FY 2022 5y median 7.8× FY 2025
Quick Ratio 9.8×
FY 2022 5y median 7.2× FY 2025
Debt / Equity 0.0×
FY 2022 5y median 0.0× FY 2025
Net Debt / EBITDA -0.6×
FY 2022 5y median 1.2× FY 2025
Interest Coverage 0.0×
FY 2022 5y median 0.0× FY 2025
Dividends
Dividend Yield 0.0%
FY 2022 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2022 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31